Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Standard Biotools (LAB) over the last 17 years, with Q3 2025 value amounting to 0.74.

  • Standard Biotools' Equity Ratio rose 315.13% to 0.74 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.74, marking a year-over-year increase of 315.13%. This contributed to the annual value of 0.77 for FY2024, which is 26810.14% up from last year.
  • According to the latest figures from Q3 2025, Standard Biotools' Equity Ratio is 0.74, which was up 315.13% from 0.76 recorded in Q2 2025.
  • Standard Biotools' 5-year Equity Ratio high stood at 0.78 for Q1 2025, and its period low was 0.46 during Q4 2023.
  • Over the past 5 years, Standard Biotools' median Equity Ratio value was 0.35 (recorded in 2021), while the average stood at 0.26.
  • As far as peak fluctuations go, Standard Biotools' Equity Ratio crashed by 42146.94% in 2023, and later soared by 38398.97% in 2024.
  • Over the past 5 years, Standard Biotools' Equity Ratio (Quarter) stood at 0.34 in 2021, then tumbled by 160.73% to 0.21 in 2022, then plummeted by 119.56% to 0.46 in 2023, then surged by 268.1% to 0.77 in 2024, then fell by 3.86% to 0.74 in 2025.
  • Its Equity Ratio stands at 0.74 for Q3 2025, versus 0.76 for Q2 2025 and 0.78 for Q1 2025.